276 related articles for article (PubMed ID: 4062970)
1. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
Dawicki DD; Agarwal KC; Parks RE
Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
[TBL] [Abstract][Full Text] [Related]
3. Adenosine metabolism in human whole blood. Effects of nucleoside transport inhibitors and phosphate concentration.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1988 Feb; 37(4):621-6. PubMed ID: 3342099
[TBL] [Abstract][Full Text] [Related]
4. Significance of plasma adenosine in the antiplatelet activity of forskolin: potentiation by dipyridamole and dilazep.
Agarwal KC; Zielinski BA; Maitra RS
Thromb Haemost; 1989 Feb; 61(1):106-10. PubMed ID: 2749584
[TBL] [Abstract][Full Text] [Related]
5. Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences.
Agarwal KC; Buckley RS; Parks RE
Thromb Res; 1987 Jul; 47(2):191-200. PubMed ID: 2821650
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine.
Plagemann PG; Kraupp M
Biochem Pharmacol; 1986 Aug; 35(15):2559-67. PubMed ID: 3741459
[TBL] [Abstract][Full Text] [Related]
7. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
Plagemann PG; Woffendin C
Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
[TBL] [Abstract][Full Text] [Related]
9. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx.
Prus KL; Averett DR; Zimmerman TP
Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735
[TBL] [Abstract][Full Text] [Related]
10. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
[No Abstract] [Full Text] [Related]
11. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate.
Plagemann PG
J Cell Physiol; 1986 Sep; 128(3):491-500. PubMed ID: 3488996
[TBL] [Abstract][Full Text] [Related]
12. Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.
Jarvis SM
Mol Pharmacol; 1986 Dec; 30(6):659-65. PubMed ID: 3785142
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole.
Shuralyova I; Tajmir P; Bilan PJ; Sweeney G; Coe IR
Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H627-32. PubMed ID: 14551048
[TBL] [Abstract][Full Text] [Related]
14. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
Endres CJ; Sengupta DJ; Unadkat JD
Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
[TBL] [Abstract][Full Text] [Related]
15. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
Gu JG; Nath A; Geiger JD
J Neurochem; 1996 Sep; 67(3):972-7. PubMed ID: 8752102
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine and p-chloromercuriphenyl sulfonate.
Jarvis SM; Young JD
J Membr Biol; 1986; 93(1):1-10. PubMed ID: 3025447
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial action of nitrobenzylthioinosine in combination with purine nucleoside antimetabolites.
Gero AM; Scott HV; O'Sullivan WJ; Christopherson RI
Mol Biochem Parasitol; 1989 Apr; 34(1):87-97. PubMed ID: 2651920
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside transport inhibition and fMLP-stimulated whole blood luminescence.
Ver Donck KL; Verheyen WJ; Van Belle H
J Mol Cell Cardiol; 1991 Jul; 23(7):783-5. PubMed ID: 1791629
[TBL] [Abstract][Full Text] [Related]
19. Saturable, high affinity binding of the nucleoside transport inhibitor, nitrobenzylthioinosine, to guinea pig cardiac membranes.
Williams EF; Clanachan AS
Eur J Pharmacol; 1983 Jan; 87(1):133-6. PubMed ID: 6132821
[TBL] [Abstract][Full Text] [Related]
20. Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblast.
Barros LF; Bustamante JC; Yudilevich DL; Jarvis SM
J Membr Biol; 1991 Jan; 119(2):151-61. PubMed ID: 1904498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
